Back to Top

m-RESIST understanding treatment-resistant schizophrenia - newsletter available online!

1 August 2017

m-RESIST project has published its second newsletter. Issue 2 focuses on presenting the latest achievements and results of the project. In this newsletter, you will have the opportunity to read the project's news, past events and publications as well as upcoming events.

m-RESIST is a 36-months EU co-funded project under the Horizon 2020 research and innovation framework program. The Project aims to develop a therapeutic program that provides clinical and psychological tools that draw on the support of mobile devices. We consider this m-Health approach will help to actively involve patients with treatment-resistant schizophrenia and their caregivers, as well as to make them more capable of self-managing their own illness.

Launched in January 2015, m-RESIST is expected to implement a model of analysis, in order to move forward in understanding treatment-resistant schizophrenia. Project activities will help to predict patient’s behaviour and will allow the establishment of a reaction alert system, as well as to draw up protocols and recommendations to give clinicians support in their medical decisions. By linking data mining tools with a high-level predictive model, m-RESIST will bring forth a new technical focus for health treatments. This will allow the behaviour patterns found in many patients’ data to be analysed in order to identify the risks and shortcomings of the treatments.

For more information about the project click here!
For the "m-RESIST Newsletter Issue 2-July 2017" click here!